CVS Health Corp (CVS · NYSE)
CVS · MARKET VIEW
Market view · as of Jun 2, 2026
Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
81.6%
-7.6% vs 52w high · +10.4% 1mo
Price (last ~year)
CVS Health Corp, a diversified healthcare provider with a $115.62 billion market capitalization, reported $100.43 billion in revenue for the quarter ending March 31, 2026, representing a 6.1% year-over-year increase. The company has exceeded earnings estimates in each of the last four quarters, contributing to a 63.1% year-over-year earnings growth. Financial leverage remains a factor, with $78.34 billion in total debt and a 5.1x debt-to-EBITDA ratio. Shares are currently trading at $90.62, a 16.1% gain over the last three months, compared to an analyst price target of $102.85.
Valuation
- Market cap
- $115.62B
- P/E
- 39.75
- PEG
- 0.255
- P/B
- 1.493
- P/S
- 0.285
- EV/EBITDA
- 16.36
- Beta
- 0.592
- Analyst target
- $102.85
Quality & returns
- Gross margin
- 13.4%
- Operating margin
- 4.1%
- Profit margin
- 0.7%
- ROE
- 3.8%
- ROA
- 2.7%
Price movement
- Last
- $90.62
- 1-month
- +10.4%
- 3-month
- +16.1%
- RSI (14)
- 46
- vs SMA200
- +17.0%
- 52-wk position
- 81.6% -7.6% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $100.43B | $4.68B | $2.94B | $5.83B |
| 2025-12-31 | $105.69B | $2.11B | $2.94B | $3.29B |
| 2025-09-30 | $102.87B | $-3.21B | $-3.98B | $-1.56B |
| 2025-06-30 | $98.92B | $2.38B | $1.02B | $3.58B |
Recent news
- Neutral Eli Lilly issues data sharing ultimatum to 340B hospitals · 2026-06-02
- Somewhat-Bullish Medline completes $2 billion note issuance and term loan refinancing · 2026-06-02
- Neutral BW Gestao de Investimentos Ltda. Sells 110,000 Shares of CVS Health Corporation $CVS · 2026-06-02
- Bullish Caring for two generations, one day at a time · 2026-06-02
- Neutral Assessing agilon health (AGL) Valuation After A Sharp Share Price Rebound · 2026-06-02
- Neutral CVS (CVS) chief medical officer surrenders shares for tax withholding · 2026-06-01
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)